US Biotech Firm Moderna Says Vaccine 94.5% Effective for COVID-19

By Kyodo News 17 November 2020

WASHINGTON—Biotechnology company Moderna Inc. said Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19, making it the second US firm to show promising results in developing a vaccine against the coronavirus pandemic.

The Massachusetts-based company said it plans to apply for emergency use authorization in the United States in the coming weeks and also submit authorization applications to global regulatory agencies.

Read more.

You may also like these stories:

Trump Says Biden ‘Won’ Because of Rigged US Election

England to Enter New Lockdown Amid Second Wave of Coronavirus Cases

France, Germany to Reimpose Lockdowns to Contain Virus Spread